Aspen Neuroscience is a San Diego-based biotechnology company headed by Damian McDevitt, President and CEO. The second product in their pipeline is a gene-corrected autologous neuron replacement therapy for genetic variants that increase the risk of Parkinson’s disease (ANPD002).
×
Aspen Neuroscience � ANPD002
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD